Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells
Provided herein are constructs of micro-aggregate multicellular, minimally polarized grafts containing Leucine-rich repeat-containing G-protein coupled Receptor (LGR) expressing cells for wound therapy applications, tissue engineering, cell therapy applications, regenerative medicine applications, medical/therapeutic applications, tissue healing applications, immune therapy applications, and tissue transplant therapy applications which preferably are associated with a delivery vector/substrate/support/scaffold for direct application.
1. A composition, comprising
a cryoprotectant;
a first tissue section comprising a dermal segment, an epidermal segment, and a segment of a follicular unit of a mammalian cutaneous tissue specimen, wherein the dermal segment and the epidermal segment are outside the follicular unit; the segments are interconnected; and the segment of the follicular unit comprises living LGR-expressing stem cells that are exposed; and
a second tissue section separated from the first tissue section, the second tissue section consisting of a second dermal segment and a second epidermal segment, wherein the second dermal segment and second epidermal segment are interconnected;
wherein the composition is capable of regenerating functional tissue comprising epidermis, dermis, and appendages when transplanted to a damaged tissue site in a subject in need thereof.
2. The composition of claim 1 , wherein the mammalian cutaneous tissue specimen is a human cutaneous tissue specimen.
3. The composition of claim 1 , wherein the cryoprotectant comprises dimethylsulfoxide.
4. The composition of claim 1 , further comprising a cell sustaining media.
5. The composition of claim 4 , wherein the cell sustaining media comprises pulse rescue media.
6. The composition of claim 1 , further comprising one or more supplements selected from growth factors, LGR specific binding elements, or combinations thereof.
7. The composition of claim 6 , wherein the LGR specific binding elements are selected from the group consisting of R spondin, an epidermal-derived growth factor (EDGF), a platelet-derived growth factor (PDGF), a Wnt protein, a vascular endothelial growth factor (VEGF), an antimicrobial peptide, and combinations thereof.
8. The composition according to claim 1 , wherein the living LGR-expressing stem cells are LGR4-expressing cells, LGR5-expressing cells, LGR6-expressing cells, or any combination thereof.
9. The composition of claim 1 , further comprising processed fat and hypodermal elements.
10. A pharmaceutical composition comprising the composition of claim 1 and a deliverable vehicle.
11. A pharmaceutical composition comprising the composition of claim 1 and a multidimensional support.
12. The composition of claim 1 , wherein the composition is cryopreserved.
13. The composition of claim 1 , wherein the segment of the follicular unit comprises a segment of a bulge.
14. The composition of claim 1 , wherein the segment of the follicular unit comprises a segment of a bulb.
15. A composition, comprising a cryoprotectant; and
a tissue section comprising a dermal segment, an epidermal segment, and a segment of a follicular compartment of a mammalian cutaneous tissue specimen, wherein the segments are interconnected and the segment of the follicular compartment comprises living LGR-expressing stem cells that are exposed;
wherein the composition is prepared by a process comprising separating fat and hypodermal elements from the mammalian cutaneous tissue specimen ex vivo to provide remaining cutaneous elements containing an epidermal compartment, a dermal compartment, and the follicular compartment; and segmenting the epidermal compartment, the dermal compartment, and the follicular compartment to open the follicular compartment and prepare the tissue section, and the composition is capable of regenerating functional tissue comprising epidermis, dermis, and appendages when transplanted to a damaged tissue site in a subject in need thereof.
16. The composition of claim 15 , further comprising a second tissue section comprising a second dermal segment and a second epidermal segment, wherein the second dermal segment and the second epidermal segment are interconnected.
17. The composition of claim 15 , wherein the mammalian cutaneous tissue specimen is a human cutaneous tissue specimen.
18. The composition of claim 15 , wherein the cryoprotectant comprises dimethylsulfoxide.
19. The composition of claim 15 , further comprising a cell sustaining media.
20. The composition of claim 19 , wherein the cell sustaining media comprises pulse rescue media.
21. The composition of claim 15 , further comprising one or more supplements selected from growth factors, LGR specific binding elements, or combinations thereof.
22. The composition of claim 21 , wherein the LGR specific binding elements are selected from the group consisting of R spondin, an epidermal-derived growth factor (EDGF), a platelet-derived growth factor (PDGF), a Wnt protein, a vascular endothelial growth factor (VEGF), an antimicrobial peptide, and combinations thereof.
23. The composition according to claim 15 , wherein the living LGR-expressing stem cells are LGR4-expressing cells, LGR5-expressing cells, LGR6-expressing cells, or any combination thereof.
24. A pharmaceutical composition comprising the composition of claim 15 and a deliverable vehicle.
25. A pharmaceutical composition comprising the composition of claim 15 and a multidimensional support.
26. The composition of claim 15 , wherein the composition is cryopreserved.
27. The composition of claim 15 , wherein the segment of the follicular compartment comprises a segment of a bulge.
28. The composition of claim 15 , wherein the segment of the follicular compartment comprises a segment of a bulb.
29. A composition, comprising
a cryoprotectant;
a first tissue section comprising a dermal segment, an epidermal segment, and a segment of a follicular unit of a mammalian cutaneous tissue specimen, wherein the dermal segment and the epidermal segment are outside the follicular unit; the segments are interconnected; and the segment of the follicular unit comprises living LGR-expressing stem cells that are exposed; and
a second tissue section separated from the first tissue section, the second tissue section consisting essentially of a second dermal segment and a second epidermal segment, wherein the second tissue section is outside any follicular unit; and the second dermal segment and second epidermal segment are interconnected;
wherein the composition is capable of regenerating functional tissue comprising epidermis, dermis, and appendages when transplanted to a damaged tissue site in a subject in need thereof.